Abstract: Background: This study aimed to explore the course of depression and anxiety in chronic hepatitis C patients. Methods: Data were combined from two studies: (1) Hospital Anxiety and Depression Scale (HADS) scores in 395 con-secutive Australian outpatients from 2006 to 2010 formed the baseline measurement; and (2) Depression Anxiety Stress Scales (DASS) scores in a survey of a sub-sample of these patients in 2011 formed the follow-up measurement. After converting DASS to HADS scores, changes in symptom scores and rates of case-ness (8), and predictors of follow-up symptoms were assessed. Results: Follow-up data were available for 61 patients (70.5 % male) whose age ranged from 24.5 to 74.6 years (M=45.6). The time to follow-up ran...
Objectives: Interferon (IFN) treatment has many neuropsychiatric side effects such as depression and...
[[abstract]]PURPOSE: Depression and anxiety have been reported to increase the risk of infectious di...
Background and aimTreatment of hepatitis C with direct-acting antiviral agents (DAA) has few side ef...
BACKGROUND: This study aimed to explore the course of depression and anxiety in chronic hepatitis C ...
BACKGROUND: This study aimed to explore the course of depression and anxiety in chronic hepatitis C ...
OBJECTIVE: The present study aimed to assess the prevalence and predictors of anxiety and depression...
Objective: The aims of this study were to assess symptoms of depression, anxiety, and stress and ass...
In those living with chronic hepatitis C (CHC), co-morbid depression and anxiety are highly prevalen...
Background: Co-morbid anxiety and depression are associated with hepatitis C. Comorbid depression is...
Abstract Background Mood and anxiety symptoms in chronic hepatitis C (CHC) may be related to...
Objective: The aim of our study was to determine the frequency of depression, addiction and inductio...
BACKGROUND AND AIM:Treatment of hepatitis C with direct-acting antiviral agents (DAA) has few side e...
Background: All around the globe, the health of people has suffered due to infection of hepatitis C....
UNLABELLED: Our objective was to assess the extent and risk factors for depression and poor physical...
Objective: To estimate the frequency of depression among hepatitis C positive patients. Study Desi...
Objectives: Interferon (IFN) treatment has many neuropsychiatric side effects such as depression and...
[[abstract]]PURPOSE: Depression and anxiety have been reported to increase the risk of infectious di...
Background and aimTreatment of hepatitis C with direct-acting antiviral agents (DAA) has few side ef...
BACKGROUND: This study aimed to explore the course of depression and anxiety in chronic hepatitis C ...
BACKGROUND: This study aimed to explore the course of depression and anxiety in chronic hepatitis C ...
OBJECTIVE: The present study aimed to assess the prevalence and predictors of anxiety and depression...
Objective: The aims of this study were to assess symptoms of depression, anxiety, and stress and ass...
In those living with chronic hepatitis C (CHC), co-morbid depression and anxiety are highly prevalen...
Background: Co-morbid anxiety and depression are associated with hepatitis C. Comorbid depression is...
Abstract Background Mood and anxiety symptoms in chronic hepatitis C (CHC) may be related to...
Objective: The aim of our study was to determine the frequency of depression, addiction and inductio...
BACKGROUND AND AIM:Treatment of hepatitis C with direct-acting antiviral agents (DAA) has few side e...
Background: All around the globe, the health of people has suffered due to infection of hepatitis C....
UNLABELLED: Our objective was to assess the extent and risk factors for depression and poor physical...
Objective: To estimate the frequency of depression among hepatitis C positive patients. Study Desi...
Objectives: Interferon (IFN) treatment has many neuropsychiatric side effects such as depression and...
[[abstract]]PURPOSE: Depression and anxiety have been reported to increase the risk of infectious di...
Background and aimTreatment of hepatitis C with direct-acting antiviral agents (DAA) has few side ef...